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Oligodendrocytes: the myelinating glia of the CNS: 
Oligodendrocytes (OL) branch and wrap multiple axonal targets in myelin in a process 
termed myelination. Regularly spaced polarized domains along the axons are wrapped 
concentrically by Schwann cells (SC) in the peripheral nervous system (PNS) and by OLs in the 
central nervous system (CNS). These domains include the node, paranode, juxtaparanode and 
internode.  
Each myelin segment is broken up by 1 µm wide nodes of Ranvier, where action potentials 
are regenerated by Na+ gated voltage channels. Initially understood to allow for faster impulse 
propagation in axons, myelination has also been implicated in supporting long-term integrity of 
myelinated axons (Nave, 2010). Whether an axon becomes myelinated has functional 
consequences on how neurons transmit signals. Myelination plays a central role in modulating 
network activity in the brain (Fields, 2008).  
The paranode is a region in myelinated nerve fibers where the terminal myelin loops form 
specialized septate-like junctions with the axolemma, the cell membrane of an axon (Thaxton and 
Bhat, 2009). These junctions are adjacent to the nodes of Ranvier and are thought to hinder free 
diffusion between the nodal space and the juxtaparanodal space (Pedraza et al. 2001). The 
formation of the paranodal region is critical to delineation and segmentation of axonal domains in 
nerve fibers that allow for proper conduction of the nerve impulse. 
The juxtaparanode is a potassium channel-rich region that lies underneath the compact 
myelin sheath, proximal to the paranodes. The significance of localizing potassium channels in 
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this domain is thought to counteract instability of excitability as well as repolarizing the action 
potential (Thaxton and Bhat, 2009).  
The portion of nerve fiber between two nodes is called the internodal region and it 
comprises 99% of total segment length. It is relatively free of specialized structures despite this it 
is an active site of axon-glial interactions mediated by Myelin-associated glycoprotein (MAG) as 
it localizes to the inner glial membrane (Salzer, 2003).  
A transgenic mouse line displaying sparsely labeled OLs illustrate that a single OL can 
produce anywhere between 20-100 internodes with lengths that vary from 40-400 um. Variations 
in numbers and lengths of myelin internodes produced by OLs suggest that endogenous cues exist 
to achieve the precise and efficient myelination of axons during development (Chong et al., 2012). 
Even though subpopulations of oligodendrocyte progenitor cells (OPCs) are specified from 
different domains in a temporal-specific manner, the majority of OPCs differentiate and myelinate 
axons regardless of origin. When specific OPC populations are eliminated, OPCs from different 
regions can replace the lost OPCs, resulting in a normal phenotype (Kessaris et al., 2006). 
Oligodendrocytes origin and early development: 
OLs originate from multipotent neural progenitor cells (NPCs) residing in the pMN 
domain of ventral spinal cord (Emery and Lu, 2015). Neural progenitors from this domain will 
give rise to motor neurons and then to oligodendrocytes progenitors cells (OPCs) (Masahira et 
al., 2006).  
The developmental progression of NPC to fully mature OL is as follows: primitive or 
uncommitted OPCs (OLIG1/2 +, A2B5 +, PDGFRα-low), committed OPCs (PDGFRα-high, 
NG2+), differentiating immature oligodendrocytes (O4+/CNP+), differentiated oligodendrocytes 
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(CC1+), and mature myelinating oligodendrocytes (MBP+, PLP+, MOG+). The differentiation 
process requires precise coordination of extensive extracellular and intracellular factors (Gregath 
and Lu, 2018).  
Epigenetics and Oligodendrocyte Development:  
 A term coined by British developmental biologist Conrad Waddington in 1942 means 
‘above genetics’ was conceived to describe the developmental processes connecting genotype and 
phenotype. Waddington understood that there appeared to be a “concatenation(s) of processes 
linked together in a network, so that a disturbance at an early stage may gradually cause more and 
more far reaching abnormalities in many different organs and tissues” (Waddington, 1942). His 
developmental studies revealed that embryo fruit flies could be persuaded to express different 
thorax and wing structures by changing the environmental temperature or through a chemical 
stimulus (Waddington, 1957). Since then, a variety of biological phenomena have been labelled as 
epigenetic including, paramutation, imprinting, X inactivation, histone modifications and cellular 
differentiation. Because normal development depends on communication between cells, a 
hormone, morphogen or growth factor that can initiate an epigenetic change that may be heritable. 
The environment of a cell is particularly important in determining its properties and fate (Holliday, 
2006). Currently, epigenetics is understood as “the study of any potentially stable and, ideally, 
heritable change in gene expression or cellular phenotype that occurs without changes in Watson-
Crick base-pairing of DNA” (Goldberg, Allis and Bernstein, 2007).   
Chromatin can be in the open form (euchromatin), allowing transcriptional machinery 
access, or a closed form (heterochromatin), which does not allow for transcription. Modification 
of histones plays a critical role in development. The basic unit of chromatin is the nucleosome, 
composed of a core octamer of histones (H2A, H2B, H3 & H4) surrounded by 146 base pairs of 
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DNA. Post-translational modifications of specific amino acid residues on the tails of the histones 
transform the transcriptional activity of genes and the access of the transcriptional machinery to 
DNA. Chromatin modification can be separated into 2 groups of enzymatic activities. The first is 
responsible for secondary modification of histones, the second includes enzymes using ATP to 
unwind nucleosomes and affect DNA/histone interactions. (Liu and Casaccia, 2010). 
Understanding which genomic regions are characterized by heterochromatin and euchromatin 
within each cell allows for the definition of cell-specific patterns of gene expression. The 
oligodendrocyte lineage, progenitor nuclei are characterized by euchromatin while myelinated 
oligodendrocyte nuclei are characterized by heterochromatin (Tsai and Casaccia, 2019). 
Acetylation, deacetylation, methylation and sumoylation are some of the modifications that 
can occur. Addition or removal of chemical groups on specific residues of histones contributes to 
transcriptional activation or repression. Interestingly, the same modification on a different residue 
produces opposing results. Deposition of a methyl group on lysine 4 of histone H3 is associated 
with gene activation, while methylation of lysine 27 (H3K27me3) results in repression. Removal 
of the methyl groups from these residues has the opposite effect, activation (Liu and Casaccia, 
2010).  
H3K27me3, is associated with downregulation of nearby genes it is catalyzed by a family 
of histone methyltransferases (HMTs), and methylated lysine residues are bound by specific 
domains called chromodomains. Oligodendrocyte lineage-specific ablation of the DNA 
methyltransferase (Dnmt1) in mice severely impaired developmental myelination and resulted in 
aberrant splicing and loss of immature oligodendrocytes, due to activation of an endoplasmic 
reticulum stress response (Moyon et al., 2016 & Tsai and Casaccia, 2019). The undifferentiated 
state of ESCs is a result of interactions between activating events and repressive mechanisms 
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involving transcription factors Oct4, Sox2, Nanog and deposition of repressive histone marks 
(H3K27me3) (Boyer et al., 2006). Neural precursors remove the H3K4me3 activation mark but 
keep the repressive H3K27me3 on mesodermal or endodermal genes resulting in silencing of genes 
associated with either lineage choice. Simultaneously, in regions containing neural genes 
H3K27me3 are removed while H3K4me3 are retained (Bernstein et al., 2006). The enzyme 
responsible for the deposition of H3K27me3, EZH2 (enhancer of Zeste Homolog2), was also 
identified as an important mediator of OPC specification in neural stem cells (NSC) by repressing 
neuronal and astrocytic genes as well as genes regulating pluripotency (Sher, Boddeke, Olah, & 
Copray, 2012; Tsai and Casaccia, 2019).  
Among the post-translational modifications, acetylation of lysine residues in the N-
terminal tail of nucleosomal histones mediated by histone acetyl transferases (HATs) is associated 
with transcriptionally competent chromatin. The acetylation of histone H3 lysine 9 (H3K9Ac) 
marks active promoters. Acetylated lysine residues are bound by α-helical structural motifs called 
bromodomains, which recruit transcription factors, coactivators, and components of the 
transcription initiation complex (Tsai and Casaccia, 2019). 
Histone deacetylation by contrast is catalyzed by histone deacetylases (HDACs) and is 
functionally associated with transcriptional repression (Liu et al., 2007). HDACs are separated into 
4 classes based on sequence homology, subcellular localization, and tissue distribution. Class III 
includes nuclear and cytosolic enzymes called Sirtuins, of which Sirt2 has been shown to regulate 
oligodendrocyte differentiation.  
OLs from younger mice remyelinate more efficiently than those from old mice, recent 
evidence attributes the difference to epigenetic changes linked to recruitment of histone 
deacetylases (HDACs). Efficient recruitment of HDACs in young mice corresponds to the 
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silencing of transcriptional repressors in OLs. Reduced recruitment of HDACs in older animals 
leads to the accumulation of repressors, and hampers differentiation and remyelination. Old and 
young OLs were exposed to similar microenvironments, an ideal way to test the role of their 
intrinsic capacity to remyelinate. Surprisingly, when old OLs are exposed to a youthful systemic 
environment, their ability to differentiate and remyelinate is revitalized to levels found in younger 
cells. Findings suggest that environmental signals dominate intrinsic mechanisms to modulate the 
differentiation and myelination of oligodendroglia (Shen et al., 2008). 
It is also established that actin plays important roles in the cell nucleus. In vitro studies 
show nuclear actin associates with all three RNA polymerases, suggesting it plays a critical role 
in communication between the cytoplasm and the nuclear expression of protein encoding genes 
(Hofmann et al. 2004; Hu, Wu and Hernandez, 2004; Kukalev, Nord, Palmberg, Bergman, & 
Percipalle, 2005; Philimonenko et al., 2004). Nuclear actin associates with and inhibits the activity 
of HDAC1 and HDAC2 (Serebryannyy, Cruz & de Lanerolle, 2016), thereby supporting an overall 
function for the integrity and activity of the BRG1-containing SWI/SNF chromatin remodeling 
complex (Kapoor & Shen, 2014). Nuclear actin appears to act as a regulator of histone acetylation 
and transcriptional activation.  Actin was shown to co-immunoprecipitate with both LINC complex 
(a protein complex that acts a direct physical connection between the plasma membrane and 
nuclear chromatin) and repressive H3K9me3 histone mark in protein extracts from white matter 







Epigenetic Marker Function 
HDAC2 Closed chromatin– transcriptional incompetence 
H3K9Ac Open chromatin- transcriptional activation 
H3K27me3 Closed chromatin- transcriptional incompetence 
Table 1. Epigenetic markers of interest in OL development and their effects on transcription. 
Mechanotransduction affects the epigenetic state of cells in the CNS 
 It is well established that forces exerted at the cell surface or cytoskeleton can induce rapid, 
subnuclear deformations by propagating through the cytoskeleton and the LINC complex 
(Maniotis et al., 1997). The decision of NSCs to differentiate into either neurons, oligodendrocytes, 
or astrocytes is influenced by the stiffness of their environment. NSCs were directed toward the 
neuronal lineage when plated on soft gels (0.1-0.5kPa) but when plated on slightly stiffer gels (1-
10kPa) they could be directed toward glial lineages (Tsai and Casaccia, 2019), while increased 
extracellular matrix rigidity results in significant reduction in OL branching complexity (Urbanski 
et al. 2016). In vitro studies have also shown that increased matrix stiffness promotes a reactive 
phenotype in astrocytes and other glia (Lu et al., 2010; Janmey and Miller, 2010). OPCs from the 
CNS are mechanosensitive. Cell survival, proliferation, migration, and differentiation vary with 
mechanical stiffness of the environment these are maximized at an intermediate gel stiffness over 




Non-muscle myosin II: a cytoskeletal protein with multiple cellular functions 
NMII in the cytosol: 
Non-muscle myosin II (NMII) is a major contributor to cell organization, polarity, and 
differentiation, with altered NMII activity linked to several pathologies (Newell-Litwa, Horwitz 
and Lamers, 2015). For these reasons NMII is an important target for study and therapeutics.  
NMII crosslinks actin filaments to form actomyosin filament bundles. These actomyosin 
bundles generate contractile forces capable of deforming the cell membrane, affecting many 
cellular functions including migration and neuronal synaptogenesis (Vicente-Manzanares, Ma, 
Adelstein and Horwitz, 2009). These forces also generate mechanical signals in a process called 
mechanotransduction which can alter gene expression. (Humphrey, Dufresne and Schwartz, 2014). 
NMII consists of a heavy chain, including a globular head domain that binds both actin and 
ATP; a neck region, which binds both essential and regulatory light chains (ELC and RLC, 
respectively); and a tail region, which homodimerizes in a helical formation, and a non-helical tail 
region that directs subcellular localization of NMII isoform.  Serine/threonine kinases regulate 
NMII activity by phosphorylation of myosin RLC. NMII filaments associate with each other in an 
anti-parallel formation allowing them to crosslink and slide actin filaments past each other 
(Newell-Litwa, Horwitz and Lamers, 2015).  
NMII in the nucleus: 
Because of its ability to regulate NMII through direct RLC phosphorylation and indirectly 
through inhibition of myosin light chain phosphatase (MLCP) RhoA-associated kinase (ROCK) is 
considered a master regulator of NMII activity. In the GTP-bound state, Rho GTPases promote 
downstream signaling through kinases like ROCK (Vicente-Manzanares, Ma, Adelstein and 
Horwitz, 2009). Guanine nucleotide exchange factors (GEFs) activate Rho GTPases by loading 
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GTP onto them, whereas GTPase-activating proteins (GAPs) stimulate GTP hydrolysis, to 
inactivate Rho GTPase signaling. RhoA activates NMII and promotes the formation of actomyosin 
filament bundles through ROCK (Katoh et al., 2001). 
RhoA/ROCK-mediated NMII activation functions downstream of inhibitory chondroitin 
sulfate proteoglycans (CSPGs), and the ROCK inhibitor Y-27632 partially rescued axon regrowth 
(Borisoff et al., 2003). blebbistatin, an NMII inhibitor, restored control axon growth on inhibitory 
substrates in vitro (Hur et al., 2011). These findings make NMII an interesting target for axonal 
regeneration therapies while other studies also show that blebbistatin and Y-inhibitor can also be 
used to affect OL branching and myelination. 
Non-Muscle myosin II is a negative regulator of OL branching and myelination 
Our laboratory has previously reported that NMII regulates myelination in both the CNS 
and PNS (Wang et al., 2008).  High levels of NMII activity prevents oligodendrocyte 
differentiation, while NMII inhibition promotes oligodendrocyte maturation and myelination 
(Wang et al., 2008,2012). In addition, NMII inhibition promotes re-myelination following brain 
lesions in mice (Rusielewicz et al. 2014).  
Levels of NMII decrease as oligodendrocytes differentiate and inhibition of NMII activity 
increases branching and myelination, suggesting that NMII is a negative regulator of 
oligodendrocyte differentiation (Wang et al, 2012). Overexpression of NMII prevents 
oligodendrocyte branching and differentiation. OPC maturation is accelerated in NMII knockout 
mice shown by a significant increase in the percentage of mature MBP+ cells. Inhibition of 
branching induced by overexpression of constitutively active RhoA can be reversed by treatment 
with Y27632 (Y-inhibitor) or blebbistatin. In non-muscle cells NMII is activated by 
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phosphorylation of myosin light chain (MLC), several kinases can phosphorylate MLC, including 
Rho-associated kinase (ROCK), a major downstream effector of RhoGTPase. In the CNS, 
activation of ROCK by RhoA has been implicated in myelin-mediated inhibition of axonal 
outgrowth and OPC differentiation following nerve injury. Activation of Fyn kinase has also been 
shown to inhibit RhoA activity, thus promoting oligodendrocyte branching (Wang et al. 2012). 
siRNA experiments were conducted to determine the responsible NMII isoforms and found 
that silencing of NMII isoforms A or B reproduces the increase in branching and myelination 
observed after total NMII inhibition. Both isoforms are expressed by oligodendrocytes, NMII-B 
being predominant.  Overexpression of NMII-A or NMII-B results in decreased morphological 
complexity of OPC. Treatment with specific NMII inhibitor blebbistatin rescues the inhibition of 
process extension observed in cells overexpressing wild-type (WT) or constitutively active (CA) 
RhoA. (Wang et al., 2012). 
Inhibition of myosin II activity in OL precursors does not interfere with their differentiation 
or their ability to form myelin but instead potentiates myelin formation in culture. Inhibition of 
myosin II activity by blebbistatin resulted in increase in the amount of myelin formed in DRG 
(dorsal root ganglia)-OL co-cultures. Also, in blebbistatin treated cultures, individual myelinating 
OL give rise to more internodes than OL in control cultures. Mean number of myelin segments 
made by a single OL in blebbistatin-treated cultures was 3-4 times more than OL in control 
cultures. Myosin II activity is not required for OL differentiation and myelination, and in the 
presence of blebbistatin, individual OLs are more branched and make more myelin. By controlling 
the spatial and localized activation of actin polymerization, myosin II regulates SC polarization 
along the axon and OL branching, and thereby their ability to form myelin (Wang et al., 2008). 
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Epigenetics states can be affected by changes in NMII activity 
 NMII inhibition in adult mouse fibroblasts using blebbistatin revealed that actin-myosin 
contractility is critical in mechano-modulation of epigenetic state and cell programming (Downing 
et al., 2013).While deleting NMIIA in mouse epidermis leads to attenuated H3K27me3 mediated 
silencing and lineage commitment, nullifying morphogenesis (Le et al., 2016). Exposure of OPCs 
to mechanical stimulus was associated with upregulation of the two upstream activators of NMII 
RhoA and ROCK-II (Jagielska et al. 2017). In vivo, ablation of this myosin removed inhibitory 
effects of rigid substrates on branching complexity of oligodendrocytes (Urbanski et al., 2016). 
Taken together it is clear that mechanosensitive proteins can affect lineage commitment of cells, 
specifically NMII inhibition has been shown to do just that by affecting the epigenetic marker 
deposition.  
Considering its role as a mechano-sensitive motor protein capable of regulating OL 
differentiation and repair, the necessity of HDAC2 for OL development and that in the presence 
of blebbistatin individual OLs are more branched and make more myelin we chose to study if there 
were any epigenetic changes brought on by NMII inhibition in OL cultures. We expected NMII 
inhibited cultures to exhibit more transcriptional silencing markers (HDAC2 and 3K27me3) 
compared to control and a decrease in transcriptional activator mark H3K9Ac was also expected 
as HDACs and H3K27me3 begin to condense the chromatin structure allowing for only essential 






Materials and Methods: 
Glial Cell purification: 
 Methods for purification of primary rat OPC from P2 rat cortices have been previously 
described (Wang, et al. 2008). Briefly, primary OPC were purified by Ran2- and A2B5+ immuno-
panning from mixed glial cultures of postnatal day 1 rat cerebral cortices. Purified OPC were 
seeded onto poly-lysine coated glass coverslips and maintained in Sato media (DMEM,100 μ g/ml 
transferrin, 100 μ g/ml BSA, 20 nM progesterone, 100 μ M putrescine, 30 nM sodium selenite, 2 
mM L- glutamine, 5 μ g/ml insulin, 60 μ g/ml N-acetyl cysteine, and 10 μ M forskolin) with 10 
ng/ml PDGF and 10 ng/ml bFGF for proliferation for three days. After this time, cultures were 
induced to differentiate in Sato containing T3 for 2-3 days (30 ng/ml). To look at the effects of 
myosin activity on differentiation and epigenetic markers expression cultures were treated with 10 
μM of either ROCK inhibitor KD25 (Calbiochem) or blebbistatin (Calbiochem).   
Immunofluorescence and imaging: 
 Cultures were fixed in 4% PFA and processed for immunocytochemistry as described 
previously (Wang, et al., 2008). Briefly, cells were blocked with 1% donkey serum and 5% BSA 
in PBS for 30 min, then incubated with primary antibody as described previously (Zhang et al., 
2006). Cultures were examined by epifluorescence or confocal microscopy. Epifluorescence 
images were acquired using a microscope (DMI 4000B; Leica) with LAS 1.7.0 software equipped 
with a digital camera (DFC350FX; Leica) and the following objectives: N PLAN 10 × /0.25 NA 
and N PLAN L40 × /0.55 NA (all from Leica). Confocal images were acquired with a laser 
scanning microscope (LSM510; Carl Zeiss, Inc.) using Plan-Apochromat 20 × /0.75 NA or 





For this study the following antibodies were used: H3K9Ac (Abcam, ab4441) , H3K9Me3 
(Abcam, ab8898) and HDAC2 (Abcam, ab12169); MBP (SMI-94; Covance); TOPRO; Actin (acti-
stain 670 phalloidin, Cytoskeleton Inc.). Secondary antibodies were purchased from Jackson 
Immuno-Research Laboratories Inc. 
Morphological Analysis: 
The numbers of OL (+T3 48 hours and 72 hours) cultures were counted in micrographs 
from 9 random low-power fields/coverslip in ImageJ 1.38v (total of 18 fields per condition per 
experiment; total of two experiments). Cells were classified according to their branching 
complexity as follows: 1) low complexity: cells with at least one or two branches extending 
directly from the cell body; 2) medium complexity: cells with processes extending from primary 
branches; and 3) high complexity: cells with processes extending from secondary branches (Table 
3). Mature OL were also identified by MBP staining. In addition, type 1 and type 2 were MBP-, 
while type 3 cells were MBP+. 
For quantitation of epigenetic markers nuclear staining, we used ImageJ 1.52p. Area, mean 
gray value (MGV) and integrated density values (INTDEN) (Table 2) were collected for each 
epigenetic marker in individual cells. When measuring area, a dim and bright object are considered 
equivalent if they are the same size. While measuring MGV, a large and small object are 
considered equivalent if they have the same brightness. Integrated density is the product of area 
and MGV so a small bright object and a large dim object would be considered equivalent. Because 
it takes into consideration both the size and concentration of the stain INTDEN was used to 
examine the changes in epigenetic markers staining. Statistical analyses (non-parametric Kruskal 
Wallis t-test, when comparing changes in marker intensity at 48 vs. 72 hours in each group, 2-way 
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ANOVA when comparing changes in intensity across different groups and treatments and Chi-
squared when comparing changes in the distribution of cell types across different treatments) were 
performed using GraphPad Prism. 
 
Table 2. Epigenetic markers were measured by calculating the area, mean gray value, and integrated 
density of the stain. https://forum.image.sc/t/intden-vs-rawintden/5147/2 
 
 
Table 3. Classification of cells by branching complexity with MBP staining. 1) low complexity: cells with 
at least one or two branches extending directly from the cell body (MBP-); 2) medium complexity: cells 
with processes extending from primary branches (MBP-); and 3) high complexity: cells with processes 







Exposure to T3 induces increased oligodendrocyte branching and MBP expression  
It is known that immature OPC maintained in media containing PDGF cells exhibit a 
simple bipolar morphology. After addition of triiodothyronine (T3), a thyroid hormone known to 
induce OPC differentiation, OPCs become more branched and eventually mature into fully mature 
MBP+ OL. 
As expected, cultures treated with T3 for 72h yielded more cells with mature morphology 
(primary and secondary branching), compared to less mature OLs which are MBP- and exhibit just 
primary branching or immature OLs which are characterized as having bipolar process branching 
(Figures 1 and 2). In control cultures treated with T3 for 48h, a total of 201 cells (average 67±3.5 
cells per field; mean±SEM) were scored as exhibiting mature morphology, while 880 OLs  
(247.7±41.6) were scored in control cultures exposed to T3 for 72h (Figure 2 and 3). The same 
trend was observed in cultures treated with drugs affecting NMII activity, i.e.  226 (75±16.6) vs. 
961 (320.3±46.6) mature OLs in blebbistatin treated cultures; and 163 (54.0±11.1) vs. 788 
(262.7±53.7) mature OL in cultures treated with the ROCK inhibitor, KD025 (Figure 2 and 3). 
This increase in branching complexity was also accompanied by increased expression of 
MBP. We found that control OPC cultures exposed to T3 for 48h had 9.56%±1.14 (mean±SEM) 
MBP+ cells compared to 58.7%±3.53 MBP+ after 72h.  The same trend was observed in 
blebbistatin 13.6%±4.5 vs 69.3%±4.45 and KD95-treated cultures 9.35%±.15 vs. 46.63%±6.7 
(Figure 4). 
Collectively, these results indicated that longer exposure to T3 leads to extensive branching 
and increased MBP expression, and that this trend is maintained following NMII inhibition. 
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Nuclear HDAC2 staining increases as OLs mature 
 We next examined the expression of HDAC2 which is known to interact with other 
transcriptional regulators to form repressive complexes and to inhibit expression of OPC 
differentiation inhibitors or block the activation of neuronal differentiation genes (Ye et al. 2009). 
Histone deacetylation by HDAC2 plays a critical role in OPC differentiation (Liu and Casaccia, 
2010).  
We performed a 2-way ANOVA statistical test to determine whether the average INTDEN 
of categorized cell types were significantly different than the average INTDEN of other 
categorized cell types within the same culture. We found that the INTDEN of HDAC2 staining 
increases significantly (p<0.0001, non-parametric t-test, 2-way ANOVA) as cells mature (from 
type 1 to type 3) in T3 (Figure 6). Also, the INTDEN values overall were higher in 48-hour T3 
treatment than 72-hour T3 treatment. (Figure 5).  
Next, we examined the effect of NMII inhibition on HDAC2 staining using 2 different 
approaches blebbistatin a direct inhibitor of NMII activity and KD25 a ROCK inhibitor. We found 
the same trend observed in control cultures, that is, as cells mature from type 1 to type 3 the 
INTDEN levels increase for control (320.3±1330, INTDEN±SD vs 4014±1717), blebbistatin 
(2454±1215, vs 4165±1771) and KD25 (2401±1330, vs 4014±1717) treatments (Figure 5). We 
found no significant differences on the average INTDEN of HDAC2 staining when comparing 
control to myosin inhibited cultures after 48h or 72h of T3 treatment, suggesting that myosin 
inhibition has no effect on the levels of HDAC2 (Figure 5).  
These results are in accordance with recent studies that found the effects of HDAC 
inhibition on OL development appear to be temporally specific. HDAC inhibitors impair the early 
phase of OPC differentiation, but do not affect myelinating gene expression after the onset of 
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myelination (Shen et al. 2005). Jointly, our results are consistent with previous work showing 
increased histone deacetylation by HDAC as a critical epigenetic regulator of OL differentiation.  
Levels of nuclear H3K9Ac were unchanged as OLs mature 
When H3K9Ac mark is deposited genes are turned on, it is associated with active 
promoters and has been shown to correlate with OL differentiation by promoting Sox2 binding 
(Lyssiotis et al., 2007) (Du et al., 2017). Unexpectedly, we found no remarkable change in 
H3K9Ac INTDEN across cell types in control or cultures treated with myosin inhibitors after 48-
hours in T3 (Figure 7 and 8). Prolonged T3 treatment significantly increased the H3k9Ac INTDEN 
(values are higher at 72 hours than at 48 hours of T3), across all conditions tested (Figure 7). 
Although the magnitude of the change is comparable between control and cultures treated with 
blebbistatin (Figure 7). Cultures treated with ROCK inhibitor KD25, showed a significant increase 
in H3K9Ac INTDEN, as cells mature from type 1 (7078±2373, mean±SD) to type 3  (8262±1958) 
(Figure 8) after 72 hours of T3 treatment (Figure 7 and 8).  
Thus, H3K9Ac levels increased after prolonged treatment with T3 in all conditions tested 
(control and myosin-inhibited), but surprisingly this increase is comparable across all cell types 
and not related to their differentiation, with the exception of cultures treated with KD25, where 
H3K9Ac levels were significantly increased after 72 hours in type 3 cells.  
Nuclear H3K27me3 staining increases as OLs mature 
Increased activity in repressive marks is expected as the cell begins to repress any 
unessential genes or any inhibitors of OL development as it differentiates and only promotes 
essential and OL specific genes.  
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  The INTDEN of H3K27me3 stain increases significantly (p<0.0001, non-parametric t-
test) as OLs mature in control and cultures treated with myosin inhibitors in 48-hour T3 (Figure 
10). Interestingly, this change is not observed after 72 hours in T3, when the INTDEN of 
H3K27me3 were significantly decreased in all conditions tested (Figure 9 and 10).  
When comparing the effects of myosin II inhibition, we found treatment with KD25 results 
in a decrease of H3K27me3 INTDEN in type 1 (2254±1108 vs 2864±1502), type 2 (2554±1035 
vs 3683±1614), and type 3 (3973±2109 vs 4708±1495) cells compared to controls after 48-hours 
in T3. Treatment with blebbistatin has the opposite effect i.e. increased H3K27me3 INTDEN in 
type 3 cells when compared to controls (5837±1982 vs 4708±1495) (Figure 9 and 10).  
Collectively, our data shows that after 48-hour T3 treatment NMII inhibition appears to 
have different appreciable effects on this repressive epigenetic mark compared to the control. 
blebbistatin appears to increase INTDEN while KD25 appears to decrease INTDEN in 
corresponding cell types compared to control. These differences are observed in the 72-hour 





Collectively our data suggests that despite being implicated in increased OL differentiation, 
NMII inhibition does not affect HDAC2 and H3K9Ac epigenetic modifications but appears to 
affect methylation marker H3K27me3. 
A unique feature of the cytoskeleton is its ability to remodel in response to force. As force 
bearing cell to cell and cell to matrix contacts through the actomyosin cytoskeleton directly link to 
the nuclear lamina and to chromatin, it has been proposed that extrinsic forces could impact 
chromatin remodeling, but any mechanisms of force-dependent chromatin remodeling remain 
elusive (Le et al., 2016).  
The epigenetic programming of stem cells into oligodendrocytes involves three sequential 
stages of lineage progression. First, pluripotent stem cells transition to neural precursors by 
repressing pluripotency genes and restricting the lineage potential to neural fate. Second, 
multipotential neural precursors to oligodendrocyte progenitors is associated with the progressive 
loss of plasticity and the repression of neuronal and astrocytic genes. Lastly, differentiation from 
oligodendrocyte progenitor into myelin-forming cells by activation of myelin genes (Liu and 
Casaccia, 2010). The ability of oligodendrocyte progenitor cells (OPCs) to acquire identity of 
myelin expressing cells or alternative fates depends on HDAC activity. According to our findings, 
this marker does not appear to be affected by NMII activity. In agreement with the current 
understanding that as OLs mature they begin to compact chromatin to silence any unessential 
genes and genes that inhibit OL development, we found that the levels of repressive marks HDAC2 
increased as OLs mature.  
The methylation mark H3K27me3 appears to be affected differently by blebbistatin and 
KD25 treatment when compared to controls. Our lab has previously shown that blebbistatin a 
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direct NMII-inhibitor promotes OL differentiation and myelin formation (Wang et al. 2008) which 
is in line with the H3K27me3 48-hour T3 data showing an increased INTDEN in blebbistatin 
cultures compared to control. Meanwhile, there is decreased INTDEN of H3K27me3 in the KD25 
ROCK-inhibitor cultures compared to control in 48-hour T3 for all cell types thus the H3K27me3 
methylation mark appears to be the most sensitive to changes in myosin activity. 
NMII is a downstream target of RhoA through Rho-kinase (ROCK), which phosphorylates 
the myosin light chain (MLC) and activates NMII. KD25 a ROCK inhibitor prevents 
phosphorylation of the myosin light chain which prevents NMII activation and promotes 
differentiation. OPCs maintained in proliferating conditions (+PDGF) have higher levels of pMLC 
compared to mature oligodendrocytes (T3+). This could explain why no difference was found in 
H3K27me3 72-hour T3 cultures as most of the cells in this culture are mature and would exhibit 
low levels of pMLC anyway, ROCK inhibitor would be more effective in proliferating conditions. 
Our previous work also showed that while inactivation of RhoA/ROCK signaling promotes 
oligodendrocyte process extension via downregulation of MLC phosphorylation, MBP expression 
was not affected by this treatment (Wang et al. 2012). Because KD25 is an indirect NMII inhibitor 
it could affect other functions of ROCK other than NMII activation. Thus, while KD25 will 
initially promote OPC branching, once cells begin to mature and express MBP, ROCK activity 
might be required for other functions such as methylation. By comparison, blebbistatin, a direct 
inhibitor of NMII motor activity, was shown to promote OL branching expression, changes that 
are compatible with enhanced differentiation and methylation. 
Future experiments should consider comparing OPCs cultured in proliferating conditions 
(+PDGF) to T3 treated cultures to better appreciate the change in epigenetic levels from immature 
progenitor cells to T3 treated cells.  This experiment compares cells cultured in different T3 
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treatments, progenitors cultured in PDGF-α and bFGF were not included. This could account for 
why we could not find any significant differences as these cells are already differentiating. More 
differentiation marker staining to label progenitors (PDGFRα+, NG2+), newly formed 
oligodendrocytes (O4+, CNPase+), differentiated oligodendrocytes (CC1+), and mature 
myelinating oligodendrocytes (MBP+) would be more effective at identifying different cell types 
without relying on morphology, especially since ROCK inhibition has been shown to affect 
morphology and not MBP expression. Also, in this study, we evaluate three markers, HDAC2, 
H3K27me3 and H3K9Ac, the latter two are specific to H3 histones. Future studies may want to 
consider other histone modifying epigenetic markers such as phosphorylation or ubiquitylation. 
Finally, chromatin immuno-precipitation (ChIP) could provide specific location in the genome that 
various histone modifications are associated with, revealing which genes are being silenced and 
which are active during different stages of developments.  
Although there is evidence linking physical stimulation to functional effects in OLs, the 













Figure 1. Representative field of HDAC2 staining in control cultures after 48 hours T3. Cells stained with 
HDAC (red), MBP (Green), Actin (Blue), Composite (right column); cells were sorted into 3 categories 
type 1 (MBP-), bipolar branching (top row), type 2 (MBP-); primary branching (center row), and type 3 
(MBP+); primary and secondary branching (bottom row). Nuclear MBP staining seen in type 1 and type 2 
is not considered specific, cells are considered MBP+ when staining is observed in the processes and 
cytoplasm. The same classification was applied for all epigenetic markers used for this study. 
 









































Figure 2. Average cell counts of OPC cultures treated with T3 for 48 hour and 72 hours in control (left), 
blebbistatin treated (middle) and KD025 treated (right) cultures separated by morphology; type1 or 
bipolar branching (white); type 2 or primary branching (gray); and type 3 or primary and secondary 
branching (blue). Graph show the mean number of cells in each category per field±SEM. (2 cultures per 
condition/experiment) An increase in type 3 cell at the expense of type1 cells was observed in all 
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Figure 3. Total cell counts of OPC cultures treated with T3 for 48 hours (left column) and 72 hours 
(right column) for all the epigenetic markers, in control (top row), blebbistatin treated (middle row) or 






































Figure 4. MBP expression of OPC cultures treated with T3 for 48 hours and 72 hours in control (left), 
blebbistatin treated (center) and KD025 treated (right) cultures. Numbers inside bars represent the mean 
number of cells per field±SEM (2 cultures per condition/experiment) *p<0.05, **p<0.01, ***p<0.001, 






























































Figure 5. Mean Integrated Density of HDAC2 stain in control (left), blebbistatin (middle), and KD25 
(right) stained OPC cultures of different branching complexity treated in T3 for 48 hours (white) and 
72 hours (gray). Values above bar represent the total number of cells counted per condition. (2 
cultures per condition/experiment) A significant increase in intensity is observed as cells mature in 
each condition in 48-hour and 72-hour T3, ****p<0.0001, 2-way ANOVA (red).  A significant 
decrease in overall HDAC2 intensity as cells differentiate after 72 hours in T3 was observed in all 





















































































































Figure 6. Integrated Densities for HDAC2 stain arranged by cell type. Points represent individual 
cells; black bar represents mean and SD (2 cultures per condition/experiment). No statistically 
significant differences were observed when comparing the same cell types across different treatments, 
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Figure 7.  Mean Integrated Density of H3k9Ac stain in control (left), blebbistatin (middle), and KD25 
(right) stained OPC cultures of different branching complexity treated in T3 for 48 hours (white) and 72 
hours (gray). Values above bar represent sample size (2 cultures per condition/experiment). A significant 
increase in intensity in KD25 treated cultures as they mature at 72 hours was observed, ****p<0.0001, 2-
way ANOVA (red). A significant increase in overall H3k9Ac intensity after 72 hours in T3 was observed 






















































































































Figure 8. Integrated Densities of each H3K9Ac stain arranged by cell type. Points represent value from 1 
cell, black bar represents mean and SD (2 cultures per condition/experiment) A decrease in intensity 






















































Figure 9. Mean Integrated Density of H3K27me3 stain in control (left), blebbistatin (middle), and KD25 
(right) stained OPC cultures of different branching complexity treated in T3 for 48 hours (white) and 72 
hours (gray). Values above bar represent the total number of cell counter per condition (2 cultures per 
condition/experiment). An increase in intensity is observed as cells mature in 48 hours T3 for all 
conditions, ****p<0.0001, 2-way ANOVA (red). A significant decrease in overall H3K27me3 intensity 
after 72 hours in T3 was observed in control and blebbistatin conditions compared to 48 hours in T3, 



























































































































Figure 10. Integrated Densities of each H3K27me3 stain arranged by cell type. Points represent value 
from 1 cell, black bar represents mean and SD (2 cultures per condition/experiment). A significant 
difference in intensity is observed between control and NMII inhibited type 3 cells cultured in T3 for 48 
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